Inotiv, Inc.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$2.8M
Cash Runway
151.3 mo
Lead Asset
—
Next Catalyst
—
Go deeper on Inotiv, Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on NOTV — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
151.3 months
D/E 8.11 · 0% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 4 sells (180d)
Key Financialsas of March 31, 2026
Cash
$15.2M
Quarterly Burn
$1.1M
Revenue
$117.7M
Free Cash Flow
-$13.8M
Total Liabilities
$625.3M
Shareholders Equity
$77.1M
Current Ratio
0.27
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Commercialization & Governance
Commercialization
- Launch Markets
- North AmericaU.K.Europe
- Commercial Strategy
- The Company utilizes integrated marketing campaigns, trade events, digital and print advertising, direct communication, newsletters, scientific webinars, and social media to promote services and products. It also leverages scientist-to-scientist communications and encourages personnel to publish scientific articles and present at professional meetings.
Governance
- Board Size
- 7
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
48
Total value held
$1.1M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,203,722 | $329K |
| geode capital management, llc | 467,135 | $127K |
| blackrock, inc. | 331,810 | $90K |
| renaissance technologies llc | 214,864 | $59K |
| jane street group, llc | 166,050 | $45K |
| vanguard fiduciary trust co | 144,720 | $40K |
| fifth third bancorp | 140,000 | $38K |
| xtx topco ltd | 132,115 | $36K |
| state street corp | 124,129 | $34K |
| mariner, llc | 120,216 | $33K |
Showing top 10 of 48 institutional holders of Inotiv, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of Inotiv, Inc.?
Mr. Robert W. Leasure Jr. is the chief executive officer of Inotiv, Inc. (NOTV).
Where is Inotiv, Inc. headquartered?
Inotiv, Inc. (NOTV) is headquartered in West Lafayette, IN, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Inotiv, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.